Kathy Salmonson
Biographic Data
| ID | 10011882 |
|---|---|
| NAME | Kathy Salmonson |
| GIVEN NAMES | Kathy |
| FAMILY NAME | Salmonson |
| SIGNATURE | SALMONSON K |
| AFFILIATIONS | Harmonic Drive (Germany) |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2026 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experience
Introduction: Psilocybin therapy has demonstrated efficacy for cancer-related anxiety and depression, but resource-intensive individual treatment models raise important questions for psychedelic public health about equitable access and scalability. In our prior Phase 1/2 study of group retreat psilocybin therapy for patients with metastatic cancer, we observed partial responders who did not achieve full therapeutic benefit. No published research …
No prominent works on this page.
A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experience
Introduction: Psilocybin therapy has demonstrated efficacy for cancer-related anxiety and depression, but resource-intensive individual treatment models raise important questions for psychedelic public health about equitable access and scalability. In our prior Phase 1/2 study of group retreat psilocybin therapy for patients with metastatic cancer, we observed partial responders who did not achieve full therapeutic benefit. No published research …
Adverse effect (1 works) · Antidepressant (1 works) · Anxiety (1 works) · Dosing (1 works) · Forensic Toxicology and Drug Analysis (1 works) · Hallucinogen (1 works) · Nausea (1 works) · Pain Management and Placebo Effect (1 works) · Psilocybin (1 works) · Psychedelics and Drug Studies (1 works)